Crescentic glomerulonephritis associated with renal cell carcinoma after cancer immunotherapy

Journal of Nephrology

Volumn 18, Issue 4, 2005, Pages 436-441

  Kai, Hirayasu ^a   Yamagata, Kunihiro ^a   Usui, Joichi ^a   Shimizu, Yoshio ^a   Hirayama, Aki ^a   Yoh, Keigyou ^a   Mase, Kaori ^a   Hirayama, Kouichi ^a   Nagase, Sohji ^a   Nagata, Michio ^a   Kawai, Koji ^a   Akaza, Hideyuki ^a   Koyama, Akio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Cytotoxic T lymphocyte therapy; Double filtration plasmapheresis; Immune complex mediated crescentic glomerulonephritis; Rapidly progressive glomerulonephritis; Renal cell carcinoma

Indexed keywords

ALPHA INTERFERON; CREATININE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ARTICLE; AUTOPSY; CANCER IMMUNOTHERAPY; CASE REPORT; COLON PERFORATION; CREATININE BLOOD LEVEL; CYTOTOXIC T LYMPHOCYTE; DEATH; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY FUNCTION; LYMPH NODE METASTASIS; MONOTHERAPY; NEPHRECTOMY; PLASMAPHERESIS; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

BIOLOGICAL RESPONSE MODIFIERS; BIOPSY; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; GLOMERULONEPHRITIS; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; MIDDLE AGED;

EID: 28244483927     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Churg J, Sobin LH. Classfication of glomerulonephritis. In: Churg J, Bernstein J, Glassock RJ, eds. Renal disease classification and atlas of glomerular diseases. Tokyo: Igaku-Shoin 1995; 3-19.
2. Skaarup P, Jorgensen T, Larsen S. Asynchronous metastasizing renal cell carcinoma associated with progressive immune complex glomerulonephritis and proteinuria. Scand J Urol Nephrol 1984; 18: 351-6.
3. Hatakeyama S, Kawano M, Konosita T, Nomura H, Iwainaka Y, Koni I, Tofuku Y, Takeda R, Nisino A, Tokunaga S, et al. A case of renal cell carcinoma associated with rapidly progressive glomerulonephritis. Nippon Jinzo Gakkai Shi 1990; 32: 1125-32.
4. Kagan A, Sinay-Trieman L, Czernobilsky B, Barzilai N, Bar-Khayim Y. Is the association between crescentic glomerulonephritis and renal cell carcinoma coincidental? Nephron 1993; 65: 642-3.
5. Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol 1995; 5: 1740-4.
6. Ahmed M, Solangi K, Abbi R, Adler S. Nephrotic syndrome, renal failure, and renal malignancy: An unusual tumor-associated glomerulonephritis. J Am Soc Nephrol 1997; 8: 848-52.
7. Sommer M, Schmidt R, Lambrecht E, Fink H, Geiger H, Lenz T. Rapidly progressive glomerulonephritis in a patient with advanced renal cell carcinoma. Nephrol Dial Transplant 1998; 13: 2107-9.
8. Karim MY, Frankel A, Paradinas FJ, Moss J. Anti-neutrophil cytoplasmic antibody-positive crescentic nephritis occurring together with renal cell carcinoma. Nephron 2000; 85: 368-70.
9. Jain S, Kakkar N, Joshi K, Varma S. Crescentic glomerulonephritis associated with renal cell carcinoma. Ren Fail 2001; 23: 287-90.
10. Huland E, Heinzer H. Renal cell carcinoma - innovative medical treatments. Curr Opin Urol 2004; 14: 239-44.
11. Krutchik AN, Buzdar AU, Akhtar M, Blumenschein GR. Immune-complex glomerulonephritis secondary to nonspecific immunotherapy. Cancer 1980; 45: 495-7.
12. Chan TM, Cheng IK, Wong KL, Chan KW, Lai CL. Crescentic IgA glomerulonephritis following interleukin-2 therapy for hepatocellular carcinoma of the liver. Am J Nephrol 1991; 11: 493-6.
13. Kawai K, Saijo K, Oikawa T, Morishita Y, Noguchi M, Ohno T, Akaza H. Clinical course and immune response of a renal cell carcinoma patient to adoptive transfer of autologous cytotoxic T lymphocytes. Clin Exp Immunol 2003; 134: 264-9.
14. Biava CG, Gonwa TA, Naughton JL, Hopper J, Jr. Crescentic glomerulonephritis associated with nonrenal malignancies. Am J Nephrol 1984; 4: 208-14.
15. Beaufils H, Patte R, Aubert P, Camey M, Kuss R, Barbagelatta M, Chomette G. Renal immunopathology in renal cell carcinoma. Virchows Arch A Pathol Anat Histopathol 1984; 404: 87-97.
16. Jindal KK. Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: Evidence-based recommendations. Kidney Int Supple 1999; 70: S33-40.
17. Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979; 300: 524-30.
18. Bolton WK. Goodpasture's syndrome. Kidney Int 1996; 50: 1753-66.
19. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 1991; 40: 757-63.
20. Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S. Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. Jama 1980; 244: 2423-6.
21. Lewis EJ. Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group. J Clin Apheresis 1992; 7: 153.
22. Wallace DJ, Goldfinger D, Pepkowitz SH, Fichman M, Metzger AL, Schroeder JO, Euler HH. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis. J Clin Apheresis 1998; 13: 163-6.
23. Akimoto T, Ando Y, Ito C, Muto S, Kusano E, Asano Y. Effect of plasmapheresis as initial monotherapy in a case of anti-neutrophil cytoplasmic autoantibody positive crescentic glomerulonephritis. Asaio J 1999; 45: 509-13.
24. Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy f6r rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999; 33: 427-33.